| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/30/2004 | CA2248854C The regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
| 03/30/2004 | CA2243504C New 19-nor-pregnene derivatives |
| 03/30/2004 | CA2239245C N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 03/30/2004 | CA2217499C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/30/2004 | CA2215470C Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 03/30/2004 | CA2178602C Microcapsules, method of making and their use |
| 03/30/2004 | CA2152907C Antiviral topical pharmaceutical compositions |
| 03/30/2004 | CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 03/30/2004 | CA2133861C Preparation for the treatment of circulatory changes |
| 03/30/2004 | CA2130755C Intermediates useful in the preparation of purine nucleoside analogues |
| 03/30/2004 | CA2127805C Composition for nasal administration |
| 03/30/2004 | CA2122922C Method and composition for treating tumors having high tyrosinase activity |
| 03/30/2004 | CA2112981C Process for the preparation of optical isomers of a amino-2 napththyridine derivative |
| 03/30/2004 | CA2102812C Cholesterol-lowering tocopherol analogs |
| 03/30/2004 | CA2091058C Methylen-oxindole derivatives and process for their preparation |
| 03/30/2004 | CA2079706C Inhibitor of atherosclerotic intimal thickening |
| 03/30/2004 | CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
| 03/30/2004 | CA2057760C Salinomycin biomass granules which are free-flowing and dust-free and have unrestricted bioavailability of active substance, and a process for the production thereof |
| 03/25/2004 | WO2004024952A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 03/25/2004 | WO2004024920A1 Preventives/remedies for neurodegenerative diseases |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024897A2 PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 03/25/2004 | WO2004024896A2 Phenyl-indole compounds |
| 03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | WO2004024868A2 Product and process for liquefaction of mucus or sputum |
| 03/25/2004 | WO2004024745A2 Complexes of 6.alpha. 9.alpha. - difluoro - 17. alpha. - [ (2 - furanylcarbonyl) oxy] - 11.beta. -hydroxy - 16- .alpha. -methyl - 3oxo- androsta- 1,4 -diene - 17 .beta. -carbothioic acid s-fluoromethyl ester |
| 03/25/2004 | WO2004024734A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 03/25/2004 | WO2004024732A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 03/25/2004 | WO2004024728A2 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/25/2004 | WO2004024726A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 03/25/2004 | WO2004024725A1 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants |
| 03/25/2004 | WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors |
| 03/25/2004 | WO2004024695A1 Novel molecules derived from noraporphine |
| 03/25/2004 | WO2004024683A2 COMPOSITIONS FOR INDUCING INCREASED LEVELS OF β-CHEMOKINES AND METHODS OF USE THEREFOR |
| 03/25/2004 | WO2004024682A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity. |
| 03/25/2004 | WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/25/2004 | WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004024669A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 03/25/2004 | WO2004024226A1 Device for delivering a viscous medical solution to the nasal membrane and method for using same |
| 03/25/2004 | WO2004024225A1 System and method for delivering a composition to the nasal membrane |
| 03/25/2004 | WO2004024213A2 Aerosolized capreomycin for inhibition of pulmonary tuberculosis |
| 03/25/2004 | WO2004024197A1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 03/25/2004 | WO2004024187A2 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 03/25/2004 | WO2004024186A2 Treatment of cyclooxygenase-3 mediated diseases and disorders |
| 03/25/2004 | WO2004024185A1 Drug or cosmetic |
| 03/25/2004 | WO2004024184A1 Sustained release preparation |
| 03/25/2004 | WO2004024168A1 Composition and method for use in intestinal cleansing procedures |
| 03/25/2004 | WO2004024167A2 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type ii diabetes |
| 03/25/2004 | WO2004024166A1 Method for preventing or reducing secondary fractures after hip fracture |
| 03/25/2004 | WO2004024165A1 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor |
| 03/25/2004 | WO2004024164A1 Stable eye drops containing latanoprost as the active ingredient |
| 03/25/2004 | WO2004024163A1 Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines |
| 03/25/2004 | WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites |
| 03/25/2004 | WO2004024160A1 Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia |
| 03/25/2004 | WO2004024158A1 Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxy-phenyl)-ethyl]-n-methylamino]-propylamino]-3-(2h)-pyridazinone as metabolic modulator |
| 03/25/2004 | WO2004024157A1 Method for improving the ability of patients suffering from lung diseases to participate in and benefit from pulmonary rehabilitation programs |
| 03/25/2004 | WO2004024156A1 Tiotropium salts for reducing respiratory mortality rate |
| 03/25/2004 | WO2004024155A1 Adhesive patch |
| 03/25/2004 | WO2004024154A1 Use of vanilloid receptor antagonists for the treatment of pain |
| 03/25/2004 | WO2004024153A2 Calcium channel blockers |
| 03/25/2004 | WO2004024152A1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 03/25/2004 | WO2004024151A1 Composition and potentiating method |
| 03/25/2004 | WO2004024150A2 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression |
| 03/25/2004 | WO2004024149A1 Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases |
| 03/25/2004 | WO2004024147A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv |
| 03/25/2004 | WO2004024146A1 Methods for using gold (iii) complexes as anti-tumor and anti-hiv agents |
| 03/25/2004 | WO2004024145A1 Anti-cancer activity of carvedilol and its isomers |
| 03/25/2004 | WO2004024144A1 Method of treating skin disorders |
| 03/25/2004 | WO2004024142A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 03/25/2004 | WO2004024141A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2004024138A1 Solid preparation containing dioctyl sodium sulfosuccinate |
| 03/25/2004 | WO2004024137A1 Drug for kidney failure containing oxaluric acid derivative |
| 03/25/2004 | WO2004024136A1 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
| 03/25/2004 | WO2004024135A1 Antiarrythmic agent |
| 03/25/2004 | WO2004024134A1 Pharmaceutical formulations of modafinil |
| 03/25/2004 | WO2004024133A1 Novel pharmaceutical formulations of modafinil |
| 03/25/2004 | WO2004024132A2 Use of no-signal cascade modulators and pharmaceutical composition |
| 03/25/2004 | WO2004024131A1 Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer |
| 03/25/2004 | WO2004024130A2 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE |
| 03/25/2004 | WO2004024129A1 Induced remission therapy |
| 03/25/2004 | WO2004024128A2 Modified release ketoprofen dosage form |
| 03/25/2004 | WO2004024127A2 Solid formulations comprising an indolinone compound |
| 03/25/2004 | WO2004024126A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 03/25/2004 | WO2004024124A1 Modified release oral dosage form |
| 03/25/2004 | WO2004024123A1 Accelerating recovery from trauma |
| 03/25/2004 | WO2004024122A1 Composition and method for moisturizing nasal tissue |
| 03/25/2004 | WO2004024096A2 Method of treating tremors |
| 03/25/2004 | WO2004024095A2 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 03/25/2004 | WO2004024094A2 Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels |
| 03/25/2004 | WO2004024093A2 Device and method for treating restenosis |
| 03/25/2004 | WO2004024089A2 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
| 03/25/2004 | WO2004024086A2 Compounds, compositions and methods |
| 03/25/2004 | WO2004024085A2 Use of pde iv inhibitors to treat angiogenesis |
| 03/25/2004 | WO2004024083A2 Methods of bone healing |